~~<i id='EB97AB5508'><strike id='EB97AB5508'><tt id='EB97AB5508'><pre id='EB97AB5508'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

WSS

Notifications
- leisure time
The Supreme Court will review a ruling striking down a domestic violence federal gun ban
log on

leisure time

focus

author：fashion 2025-09-30 01:13:21 - browse：37

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LONDON — Novo Nordisk said Monday it would acquire the German firm Cardior Pharmaceuticals in a deal worth up to $1.1 billion, picking up additional drug candidates for its pipeline of cardiometabolic medicines.

Cardior focuses on targeting RNA to address the root causes of heart disease. Its lead candidate, known CDR132L, is in Phase 2 development as a treatment for health failure.

The companies did not disclose how much Novo was paying upfront for Cardior and how much would be based on future milestones being achieved. The deal is expected to close in the second quarter.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Merck, Johnson & Johnson CEOs will testify on high drug prices

hotspot

knowledge

focus

entertainment

hotspot

0:25AMegaMillionswageringslipisheldinCranberryTownship,Pa.,Jan.12,2023.GeneJ.Puskar/AP,FileTheMegaMi

WSS

Medicare Advantage insurers face 0.2% cut to 2025 payments

Pancreatic cancer early detection could be helped by AI

Nearly two

Syphilis numbers in the United States reach record heights

Wegovy leads to weight loss. Can it treat depression, too?

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

leisure time

focus

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

The high cost of giving birth even with insurance

Why Medicare shouldn’t cover every FDA

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

ER docs worry over extreme heat as a 'mass casualty event'

Jerome Adams on the need for new antivirals for Covid

Attacks on the drug industry will lead to fewer breakthroughs

Virginia high school admissions case could be legal follow

Verily hires former Apple Health leader as chief scientific officer

hotspot

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

FTC sues over Novant Health acquisition of two N.C. hospitals

Medicare Advantage insurers face 0.2% cut to 2025 payments

'Ancient DNA,' 23andMe reveal African American ancestries

Dramatically reducing cancer deaths requires the PASTEUR Act

Medicare Advantage insurers face 0.2% cut to 2025 payments

knowledge

focus

entertainment

hotspot